FIELD: medicine; cardiology.
SUBSTANCE: invention can be used for non-invasive assessment of severity of chronic heart failure (CHF). Ergoreflex activity is determined by performing two tests: a control sample and a sample with occlusion. After each of them diastolic blood pressure, volume of minute ventilation of lungs, volume of released carbon dioxide are recorded by means of system "Oxycon Pro". Derived values are used to assess the severity of CHF as CHF II FC, CHF III FC and CHF IV FC.
EFFECT: method enables increasing the effectiveness of the conducted treatment of the patients with chronic heart failure by the accurate assessment of the severity of the disease by assessing the set of the most significant indicators.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING INITIAL STAGES OF HEART FAILURE SEVERITY DEGREE | 2002 |
|
RU2223030C2 |
| METHOD FOR EVALUATING THE SEVERITY OF CHRONIC CARDIAC FAILURE | 2004 |
|
RU2266039C1 |
| DIAGNOSTIC TECHNIQUE FOR FUNCTIONAL CLASS OF CHRONIC CARDIAC FAILURE | 2012 |
|
RU2526800C2 |
| LEFT VENTRICLE DIASTOLE MALFUNCTION SEVERITY LEVEL DIAGNOSIS OF PATIENTS WITH CHRONIC CARDIAC FAILURE | 2006 |
|
RU2325850C2 |
| METHOD OF DETERMINING LATENT SYSTOLIC DYSFUNCTION OF RIGHT VENTRICLE | 2022 |
|
RU2811760C1 |
| METHOD FOR PREDICTING THE RISK OF PROGRESSING CHRONIC HEART FAILURE IN PATIENTS WITH MYOCARDIAL INFARCTION | 2019 |
|
RU2734671C1 |
| METHOD FOR PREDICTING THE RISK OF DECOMPENSATED HEART FAILURE AGAINST THE BACKGROUND OF RHEUMATOID ARTHRITIS | 2021 |
|
RU2790190C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF VARIOUS DEGREES OF SEVERITY OF CHRONIC HEART FAILURE | 2021 |
|
RU2772359C1 |
| METHOD FOR ASSESSING BLOOD FLOW STATE IN HEALTHY INDIVIDUALS WITH CARDIOVASCULAR RISK FACTORS AND IN CARDIOVASCULAR PATIENTS | 2012 |
|
RU2508900C1 |
| METHOD FOR ULTRASONIC EARLY DIAGNOSIS OF VENOUS PULMONARY HYPERTENSION FOR PATIENTS WITH CHRONIC HEART FAILURE | 2016 |
|
RU2634633C2 |
